May 11, 2023 / 10:00AM GMT
Presentation
May 11, 2023 / 10:00AM GMT
=====================
Corporate Participants
=====================
* Andrew S. Plump
Takeda Pharmaceutical Company Limited - President of Research & Development and Representative Director
* Christophe Weber
Takeda Pharmaceutical Company Limited - President, CEO & Representative Director
* Christopher David O'Reilly
Takeda Pharmaceutical Company Limited - Global Head of IR & Global Finance
* Constantine Saroukos
Takeda Pharmaceutical Company Limited - CFO & Representative Director
* Giles Platford
Takeda Pharmaceutical Company Limited - President of the Plasma-Derived Therapies Business Unit
* Julie Kim
Takeda Pharmaceutical Company Limited - President of the U.S. Business Unit & U.S. Country Head
* Ramona Sequeira
Takeda Pharmaceutical Company Limited - President of Global Portfolio Division
=====================
Conference Call Participants
=====================
* Hidemaru Yamaguchi
Citigroup Inc.,
Takeda Pharmaceutical Co Ltd
(FRA:TKDA)
€
12.7
-0.2 (-1.55%)
Market Cap: 40.26 Bil
Enterprise Value: 68.39 Bil
PE Ratio: 45.03
PB Ratio: 0.85
GF Score: 75/100 Full Year 2023 Takeda Pharmaceutical Co Ltd Earnings Presentation Transcript
May 11, 2023 / 10:00AM GMT
Release Date Price:
€14.8
(-3.90%)
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot